Comment on: "A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-aspartate Angiotensin I in Healthy Subjects". [electronic resource]
- Drugs in R&D 03 2017
- 241-242 p. digital
Publication Type: Letter; Comment
1179-6901
10.1007/s40268-016-0155-7 doi
Angiotensin I Area Under Curve Aspartic Acid Dose-Response Relationship, Drug Double-Blind Method Healthy Volunteers Humans